WHO Global Hepatitis Programme is developing a report on barriers to access to hepatitis C medicines. To gather background information for this report, WHO is seeking applications for a short-term consultant to collect and consolidate updated information on the status of access to new hepatitis drugs in selected countries and global market information on individual drugs and drug combinations.
Please note that the deadline for applications is August 10, 2015.
High consumption of red and processed meat linked to non-alcoholic fatty liver disease and insulin resistance
Gastrointestinal hormone measurably improved symptoms of non-alcoholic fatty liver disease
Raising awareness about alcohol-related liver disease in women
Subscribe to the EASL newsletter